Suppressing miR-21 activity in tumor-associated macrophages promotes an antitumor immune response

Journal: Journal of Clinical Investigation

Published: 2019-12-02

DOI: 10.1172/jci127125

Affiliations: 10

Authors: 17

Go to article
Institutions Share
Yale Department of Pathology, United States of America (USA) 0.22
Yale Department of Therapeutic Radiology, United States of America (USA) 0.18
Yale Department of Comparative Medicine, United States of America (USA) 0.10
Yale Program in Integrative Cell Signaling and Neurobiology of Metabolism (ICSNM), United States of America (USA) 0.10
Yale Vascular Biology and Therapeutics (VBT), United States of America (USA) 0.10
Yale Bioinformatics Support Program, United States of America (USA) 0.06
Yale Center for Genome Analysis (YCGA), United States of America (USA) 0.06
Department of Physics, URI, United States of America (USA) 0.06
Department of Pharmaceutical Sciences, UConn, United States of America (USA) 0.06
Division of Nephrology, BCH, United States of America (USA) 0.06

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER